Arterial function should be focused in the follow-up treatment of COVID-19 mild patients

Jinbo Liu, Jie Chen and Hongyu Wang*

An outbreak of pneumonia named coronavirus disease 2019 (COVID-19) occurred in Wuhan in December 2019. COVID-19 has spread rapidly throughout China, even the whole world [1]. The treatment of COVID-19 has won a stage of success after the active intervention of the Chinese government. Cardiovascular damage was found in COVID-19 patients with the increasing research of COVID-19. There might be two pathways [2,3]. 

Keywords:

Published on: Feb 27, 2021 Pages: 21-22

Full Text PDF Full Text HTML DOI: 10.17352/2455-2976.000164
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat